US Stock MarketDetailed Quotes

DSNKY Daiichi Sankyo (ADR)

Watchlist
  • 28.790
  • -0.200-0.69%
15min DelayClose Jan 22 16:00 ET
  • 28.790
  • 0.0000.00%
Post 16:00 ET
54.15BMarket Cap34.44P/E (TTM)

About Daiichi Sankyo (ADR) Company

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Company Profile

SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111

Company Executives

  • Name
  • Position
  • Salary
  • Sunao Manabe
  • Executive Chairman of the Board and Chief Executive Officer
  • --
  • Takashi Matsumoto
  • Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
  • --
  • Hiroyuki Okuzawa
  • Director, President and Chief Operating Officer
  • --
  • Takashi Fukuoka
  • Director, Senior Executive Officer and Head, Global Corporate Strategy
  • --
  • Shoji Hirashima
  • Director, Senior Executive Officer and Head, Japan Business Unit
  • --
  • Kazuaki Kama
  • Chairman of the Board
  • --
  • Yasuhiro Komatsu
  • Independent Director
  • --
  • Takaaki Nishii
  • Independent Director
  • --
  • Sawako Nohara
  • Independent Director
  • --
  • Yo Honma
  • Independent Director
  • --

Trending Stocks

Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More